title: [Diagnostic performance of serum thyroglobin and iodide-131 Na scan according to the type of recurrence in differentiated thyroid carcinoma].
abstract: BACKGROUND
  There is no consensus about the best follow-up protocol in differentiated thyroid carcinoma (DTC). The aim of this study is to evaluate the usefulness and prognostic value of serum thyroglobulin (Tg) and the iodide-131 whole body scan (WBS) in DTC recurrences as a whole and according to the type of recurrence (local recurrence or distant metastases).
  
  
  METHODS
  Thirty-four patients with recurrent DTC recruited in our institution over 15 years, with a minimum 5 years of follow-up and without either distant metastases at time of diagnosis nor detectable anti-Tg antibodies were included in the study. All patients were submitted to total or near-total thyroidectomy and 131INa ablation of postsurgical thyroid remnants. The follow-up included Tg measurement and WBS performed in hypothyroid state.
  
  
  RESULTS
  Serum Tg was increased in the 67.4% of the patients and the WBS was positive in the 82.3%. In the isolated local recurrences the sensitivity of WBS was higher than Tg measurement (93.7 vs 43.7%; p < 0.05), but patients with positive Tg had a worse prognostic. By contrast, in patients with distant metastases the sensitivity of Tg was higher than WBS (83.3 vs 58.3%; p = NS). In 14 patients (41.2%) the results of WBS and Tg were in disagreement. In these cases a worse prognosis was observed when Tg was positive and WBS negative.
  
  
  CONCLUSIONS
  The sensitivity of Tg and WBS is different depending on the type of recurrence. Therefore, both tests complement each other and it is not recommended to omit one of them in the follow-up of DTC.
authors.affiliation: Sección de Endocrinología, Hospital General Vall d'Hebron, Barcelona.
authors.forename: C
authors.initials: C
authors.lastname: Zafon
authors.forename: P
authors.initials: P
authors.lastname: Galofré
authors.forename: C
authors.initials: C
authors.lastname: Hernández
authors.forename: E
authors.initials: E
authors.lastname: Gemar
authors.forename: B
authors.initials: B
authors.lastname: Obiols
authors.forename: J
authors.initials: J
authors.lastname: Mesa
authors.forename: R
authors.initials: R
authors.lastname: Simó
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D002277:Carcinoma / Q000097:blood / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000601:surgery; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000097:blood; D007457:Iodine Radioisotopes; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D011379:Prognosis; D011877:Radionuclide Imaging; D012680:Sensitivity and Specificity; D015996:Survival Rate; D013954:Thyroglobulin / Q000097:blood*; D013964:Thyroid Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000601:surgery; D013965:Thyroidectomy
chemical_list: D015415:Biomarkers; D007457:Iodine Radioisotopes; D013954:Thyroglobulin